Rapid sequence intubation in the neonate.
Rapid sequence intubation (RSI) is premedication prior to intubation that includes atropine, a sedative, and a neuromuscular blockage. Rapid sequence intubation is infrequently performed in neonates despite evidence that it is safe and effective. Neonates that experience endotracheal intubation often display apnea and cardiac arrhythmias, decreased or obstructed nasal airflow, increased systolic blood pressure, and decreased heart rate and transcutaneous oxygen tension. Infants can also experience increased anterior fontanel pressure, which can place them at greater risk for intraventricular hemorrhage. Rapid sequence intubation has been shown to facilitate better intubation conditions including no movement from the infant and better visualization of the airway. Infants receiving RSI were successfully intubated twice as fast as infants who were not premedicated. Infants with premedication also had fewer changes in baseline heart rate. Neonatal RSI can be easily and safely performed in the neonate. Knowledge and skill allow for the best conditions when intubating the infant. Future research must focus on the best combination of medications for RSI in the neonate.
Bottor
Lottie T
LT
The Children's Hospital of Philadelphia, Newborn/Infant Intensive Care Unit, Philadelphia, PA 19104, USA. bottor@email.chop.edu
D000465:Algorithms; D001285:Atropine / Q000008:administration & dosage*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage; D007224:Infant Care / Q000379:methods; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000451:nursing*; D007363:Intensive Care Units, Neonatal / Q000458:organization & administration; D007440:Intubation / Q000379:methods* / Q000451:nursing*; D017283:Neonatal Nursing / Q000458:organization & administration*; D009467:Neuromuscular Depolarizing Agents / Q000008:administration & dosage; D015404:Nursing Methodology Research; D011292:Premedication / Q000379:methods*; D014481:United States
D006993:Hypnotics and Sedatives; D009467:Neuromuscular Depolarizing Agents; D001285:Atropine